What Causes Advanced Bone Age in Children?

Advanced bone age in children occurs when the skeleton matures faster than expected for a child’s chronological age, and the causes range from normal growth variation and excess body fat to hormonal disorders, genetic syndromes, and rare skeletal conditions. The common thread linking most causes is early or excessive exposure to sex steroids, especially estrogen, which speeds up the maturation of growth plates in long bones. Understanding why a child’s bone age is ahead of schedule matters because it affects predicted adult height and can be the first clue to an underlying condition that needs treatment.

How Bone Age Is Measured and What “Advanced” Means

Bone age is assessed from an X-ray of the left hand and wrist. A doctor compares the appearance of the bones and the degree to which growth plates have started to close against a reference standard for the child’s sex. The two most widely used methods are the Greulich-Pyle atlas, which involves matching the X-ray image to a set of reference photographs, and the Tanner-Whitehouse system, which individually scores 13 specific bones and converts the total to a bone age.

1PubMed Central. Bone age assessment: comparative analysis of Greulich-Pyle and Tanner-Whitehouse 3 by pediatric radiologists and endocrinologists

A bone age that is more than about a year ahead of chronological age is generally considered “advanced.” A child whose bone age is two or more years ahead almost always warrants further investigation. Bone age can be influenced by sex, nutrition, genetics, metabolic status, and acute or chronic illness, so the number alone is never diagnostic. It is one piece of a larger puzzle.

2PubMed Central. Evaluation of Bone Age in Children: A Mini-Review

Estrogen Is the Central Player

Almost every pathway that leads to advanced bone age converges on a single hormone: estrogen. Estrogen acts directly on growth plate cartilage, speeding up the process by which growing cartilage converts to bone and the growth plates eventually fuse. This applies to both girls and boys, because males also produce estrogen through the conversion of testosterone by an enzyme called aromatase.

Research in animal models has shown that estrogen irreversibly depletes the pool of progenitor cells in the resting zone of the growth plate. Once those cells are used up faster than normal, growth plate height declines, the cartilage matures ahead of schedule, and the plates fuse sooner, capping final height. Even a brief period of elevated estrogen can permanently advance this process, because the progenitor cell loss does not reverse once the estrogen goes away.

3PubMed Central. Evidence that estrogen hastens epiphyseal fusion and cessation of longitudinal bone growth by irreversibly depleting the number of resting zone progenitor cells in female rabbits

Studies in mice lacking a functional estrogen receptor confirm the same story from the opposite direction: without the receptor, growth plates stay open longer and the animal continues to grow well beyond the normal stopping point. This mirrors what happens in rare human cases where the estrogen receptor or aromatase enzyme is nonfunctional. Those individuals keep growing into their twenties because their growth plates never receive the signal to close.

4PubMed Central. The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice

Precocious Puberty

The most commonly recognized cause of markedly advanced bone age is precocious puberty, where the body begins producing adult levels of sex hormones well before the usual age. There are two broad types, and both push bone age forward, but through different mechanisms.

Central precocious puberty occurs when the brain’s hypothalamic-pituitary system switches on too early, activating the same hormonal cascade that normally triggers puberty. The result is early breast development or testicular enlargement, a growth spurt, and rapid skeletal maturation. In girls being evaluated for early puberty, advanced bone age combined with accelerated linear growth is one of the strongest early indicators that the process is genuinely pathological rather than a benign variant.

5ScienceDirect / Jornal de Pediatria. Advanced bone age as an indicator facilitates the diagnosis of precocious puberty

Peripheral precocious puberty, by contrast, does not involve the brain’s puberty switch at all. Instead, sex steroids are produced elsewhere, such as the adrenal glands, ovaries, testes, or even an abnormal tumor. Because the hormones are flooding the body independently of the normal control system, the growth plates respond just as they would during regular puberty: maturation accelerates and bone age advances.

6PubMed. Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes

Congenital Adrenal Hyperplasia

Congenital adrenal hyperplasia (CAH) is one of the most important causes of peripheral precocious puberty and advanced bone age. In classic CAH, a genetic enzyme deficiency causes the adrenal glands to overproduce androgens. Those androgens get converted to estrogen, which then drives skeletal maturation forward. The paradox of CAH is that affected children often appear taller than their peers during childhood, yet end up shorter as adults because their growth plates close too soon.

Data from children with classic CAH due to 21-hydroxylase deficiency illustrate this clearly. During the adrenarche years, children whose bone age was accelerating were significantly taller than average, yet their predicted adult height was substantially lower than that of CAH patients whose bone age was advancing more slowly. Ultimately, final adult height was reduced in both groups.

7PubMed Central. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond

Managing CAH is a balancing act. Glucocorticoid replacement therapy is meant to suppress the overactive adrenal androgens, but if the dose is too low, androgen levels stay elevated and bone age races ahead. The form of medication matters too. One study found that children with CAH who received hydrocortisone in a carefully dosed suspension had bone age scores that averaged nearly three standard deviations lower than children on crushed tablets, suggesting that more precise dosing helps slow bone maturation.

8Journal of the Endocrine Society. Bone Age Maturation and Growth Outcomes in Young Children with CAH Treated with Hydrocortisone Suspension

Even with treatment, chronic exposure to above-normal androgen levels shortens the window during which bones can accumulate density, limiting the net benefit of the steroids on skeletal health.

9Frontiers in Adolescent Medicine. Bone health in adolescents with congenital adrenal hyperplasia: exploring the interplay between glucocorticoid therapy, hormonal imbalance and puberty

Childhood Obesity

Obesity is probably the most common reason a child is incidentally found to have an advanced bone age. The connection is driven by several overlapping mechanisms. Fat tissue is metabolically active and contains aromatase, the enzyme that converts androgens into estrogen. The more fat a child carries, the more estrogen their body produces, and the faster their growth plates mature. On top of that, obese children tend to have higher insulin levels, and insulin itself appears to stimulate growth plate receptors, promote the production of growth-signaling molecules, and further push skeletal maturation forward.

10Journal of Paediatrics and Child Health. Bone age, predicted adult height and HOMA-IR in children and adolescents with overweight and obesity: a single-centre cross-sectional study

Studies of overweight and obese children have found that the likelihood of advanced bone age rises in step with BMI, waist circumference, and weight percentile. Children with advanced bone age in these cohorts had higher insulin levels and greater insulin resistance than obese children whose bone age was on track.

11PubMed Central. Factors associated with Advanced Bone Age in Overweight and Obese Children Research specifically in prepubertal obese children has reinforced the idea that insulin and insulin resistance are linked to skeletal maturation even before puberty adds sex steroids to the picture.12PubMed. The Association between Bone Age Advancement and Insulin Resistance in Prepubertal Obese Children

For clinicians evaluating an overweight child with advanced bone age, the challenge is deciding how much of the advancement is simply a byproduct of the extra weight and how much might signal a separate endocrine problem. In most cases, a mildly advanced bone age in an otherwise healthy obese child does not require further hormonal workup. But if the advancement is extreme or accompanied by signs of early puberty, deeper investigation is warranted.

Genetic and Overgrowth Syndromes

Several genetic conditions cause the skeleton to mature faster than normal as part of a broader pattern of overgrowth or abnormal cartilage biology.

Sotos syndrome is one of the best-known overgrowth syndromes and is caused by alterations in the NSD1 gene. Children with Sotos are characteristically tall for their age, have a large head, distinctive facial features, and learning difficulties. Their bone age is typically advanced, but because their growth plates close earlier than expected, their eventual adult height usually falls within the upper end of the normal range rather than being dramatically tall.

13PubMed Central. A CASE OF SOTOS SYNDROME CAUSED BY A NOVEL VARIANT IN THE NSD1 GENE: A PROPOSED RATIONALE TO TREAT ACCOMPANYING PRECOCIOUS PUBERTY

On the other end of the height spectrum, mutations in the ACAN gene, which encodes a key structural protein in growth plate cartilage called aggrecan, can cause short stature with advanced bone age. When one copy of ACAN is nonfunctional, the cartilage in the growth plate matures prematurely. Hypertrophic cartilage cells develop too quickly and blood vessels invade the growth plate ahead of schedule, accelerating bone formation and leading to early growth plate fusion.

14PubMed Central. Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations The result is a child who is short, has bones that look older than they are, and stops growing earlier than peers.15Annals of Pediatric Endocrinology & Metabolism. Identification of a heterozygous ACAN mutation in a 15-year-old boy with short stature who presented with advanced bone age: a case report and review of the literature

ACAN mutations are worth knowing about because they can be mistaken for idiopathic short stature if the advanced bone age is not flagged as a clue. Genetic testing has made these diagnoses more accessible, and recognizing the pattern early can change management decisions.

Thyroid Excess and Other Endocrine Triggers

An overactive thyroid (hyperthyroidism) accelerates nearly every metabolic process in the body, and bone maturation is no exception. Childhood thyrotoxicosis has long been recognized as a cause of both rapid linear growth and advanced skeletal maturation. Thyroid hormones work synergistically with growth hormone and directly stimulate cartilage turnover. In most cases, treating the hyperthyroidism brings bone maturation tempo back toward normal, though some advancement may persist.

Growth hormone excess, whether from a pituitary abnormality or exogenous administration, can also push bone age forward, though this is far less common in children than the other causes discussed here. Excess cortisol from Cushing syndrome, interestingly, tends to do the opposite, delaying bone age, which is one of the ways clinicians distinguish it from simple obesity.

Environmental Exposures

There is growing interest in whether environmental chemicals that mimic or disrupt hormones can affect skeletal maturation. Phthalates, a family of chemicals found in plastics, personal care products, and food packaging, have been studied in this context. Research in girls with early onset puberty found a positive association between urinary levels of a specific phthalate metabolite and the degree of bone age advancement, suggesting that phthalate exposure may promote accelerated bone maturation.

16Pediatric Research. Artificial intelligence model system for bone age assessment of preschool children

This area of research is still early, and it is difficult to separate the effect of a single chemical from the dozens of other factors that influence a child’s growth. But the biological plausibility is there: chemicals that act like estrogen could plausibly speed up estrogen-dependent processes in the growth plate.

Constitutional Advancement of Growth

Not every child with advanced bone age has a disease. Constitutional advancement of growth (CAG) describes a normal variant in which a child grows rapidly in the first two to four years of life, reaching a high height percentile early and then growing at a normal pace until puberty, which typically arrives on the early side. Girls with idiopathic precocious puberty almost always show this growth pattern.

17The Journal of Clinical Endocrinology & Metabolism. Constitutional Advancement of Growth, a.k.a. Early Growth Acceleration, Predicts Early Puberty and Childhood Obesity

CAG is essentially the mirror image of constitutional delay of growth and puberty, which is the classic “late bloomer” pattern. Children with CAG tend to be tall in childhood but, because they mature faster, their growth plates close sooner and their adult height is often unremarkable. CAG has also been associated with a higher risk of childhood obesity, which makes sense given the shared hormonal underpinnings.

What Advanced Bone Age Means for Adult Height

The practical worry for most families is whether advanced bone age means a child will end up shorter than expected. The answer depends entirely on the cause. In conditions like central precocious puberty that are treated early, final adult height can be preserved near normal. In untreated or undertreated cases, the years of growing time lost to early fusion can cost several inches.

Height prediction methods based on bone age have important limitations. In children with growth hormone deficiency, for example, predictions made before treatment tend to underestimate adult height by roughly four centimeters, while predictions made during growth hormone therapy tend to overestimate it by a similar margin.

18PubMed Central. Adult height prediction by bone age determination in children with isolated growth hormone deficiency The takeaway is that bone age-based height predictions are useful as rough guides, not precise forecasts. They are most reliable when the child’s underlying condition is well understood and relatively stable.

Treatment Options That Slow Bone Maturation

When a child’s bone age is advancing too quickly and threatening adult height, several interventions can slow the process. The choice depends on the underlying diagnosis.

  • GnRH analogues: These drugs shut down the brain’s puberty signal and are the standard treatment for central precocious puberty. They are effective at restoring a normal adult height in that specific condition. In short children with normal puberty timing, the evidence for adding GnRH analogues is much less convincing.
  • Aromatase inhibitors: These block the conversion of androgens to estrogen, slowing the estrogen-driven maturation of growth plates. In boys with growth hormone deficiency and advanced bone age who were already receiving growth hormone, adding an aromatase inhibitor for a year measurably slowed bone age progression compared to growth hormone alone.
  • Glucocorticoid optimization: In CAH, fine-tuning glucocorticoid dosing to suppress excess adrenal androgens is the primary strategy. As noted earlier, even the formulation of the medication can make a meaningful difference in how well bone age is controlled.

19PubMed Central. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
20PubMed. Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency

These treatments aim to buy time for the skeleton, keeping growth plates open longer so the child has more years to grow. They are not interchangeable, and the decision to use any of them involves weighing potential height gain against side effects and the child’s overall clinical picture.

Psychosocial Dimensions of Early Maturation

Advanced bone age itself does not cause psychological distress, but the conditions that drive it, especially precocious puberty, can create real challenges. A child whose body looks several years older than their chronological age may face social pressure, unwanted attention, or confusion about the mismatch between their physical appearance and their emotional development.

Research on girls with idiopathic precocious puberty has found higher rates of externalizing behavior problems and greater total behavioral difficulties compared to age-matched controls, along with differences in social competence and school-related behavior.

21PubMed Central. Psychosocial aspects in girls with idiopathic precocious puberty

At the other end, concern about being unusually tall during adolescence, which can result from advanced bone age in overgrowth conditions, also carries long-term emotional weight. A study of women who had been evaluated for tall stature during adolescence found a lifetime prevalence of major depression around 28 percent, regardless of whether they had received treatment to limit their height. The strongest predictors of depression were not height itself but the subjective distress the adolescent felt about her height and whether the medical evaluation process was experienced negatively.

22PubMed. Concern about tall stature during adolescence and depression in later life

Are Today’s Children Maturing Faster Than Previous Generations?

Secular trends in skeletal maturation are real but modest. A comparison of recent and historical cohorts found that children today reach certain skeletal milestones several months earlier than children measured decades ago, with the effect peaking at around five months of advancement in girls at age 13 and four months in boys at age 15. The trend was most pronounced for indicators of growth plate fusion and was present in both sexes.

23PubMed Central. Do Secular Trends in Skeletal Maturity Occur Equally in Both Sexes?

This means that the standard bone age references, many of which were developed decades ago, may slightly overestimate how advanced a modern child’s bone age truly is relative to their peers. It also means that when a clinician sees a bone age that is a few months ahead of chronological age, part of that gap may reflect population-level changes in nutrition, body composition, and possibly environmental exposures rather than anything pathological in the individual child.

Automated Bone Age Reading

Bone age assessment has traditionally depended on a radiologist or endocrinologist comparing an X-ray to an atlas, which introduces human variability. Artificial intelligence systems designed to automate this process have shown strong performance. In one study, an AI system’s readings deviated from the reference bone age by an average of only about four months, compared to nearly ten months for human readers, and the AI cut reading time by 87 percent.

24PubMed Central. Artificial intelligence in bone age assessment: accuracy and efficiency of a novel fully automated algorithm compared to the Greulich-Pyle method

When human reviewers use AI as an assist tool rather than a replacement, their accuracy and agreement with each other both improve substantially. Agreement between readers exceeded 0.99 when AI was involved, a level of consistency that is essentially impossible for unassisted humans to maintain across large numbers of X-rays.

16Pediatric Research. Artificial intelligence model system for bone age assessment of preschool children

For families, the practical implication is that AI-assisted bone age readings are becoming standard at many pediatric centers, and they reduce the chance that a single reader’s subjective impression will skew the result. The technology does not change what advanced bone age means or what causes it, but it makes the measurement itself more reliable, which matters when treatment decisions hinge on whether bone age is truly advanced or just borderline.